https://www.databridgemarketresearch.com/reports/global-monoclonal-antibodies-market

Hybridoma Sequencing Market The global hybridoma sequencing market is experiencing significant growth, driven by advancements in antibody discovery and the rising demand for monoclonal antibodies in therapeutics. Researchers are increasingly adopting next-generation sequencing to unlock accurate variable region sequences from hybridoma cell lines, ensuring long-term reproducibility and patent protection. This technological shift optimizes the development of targeted biologics and diagnostic tools across the biotechnology and pharmaceutical sectors. Reference - https://www.wiseguyreports.com/reports/hybridoma-sequencing-market